Press release
CD Bioparticles Launches Comprehensive Homogeneous Luminescence Assay Development Services
New York, NY, United States - AUGUST 31, 2026 - With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is pleased to announce its Homogeneous Luminescence Assay Development [https://www.cd-bioparticles.com/services/homogeneous-luminescence-assay-development.html] services, to support researchers with sensitive, efficient, and high-throughput detection of biomarkers, cytokines, and other biological targets. The new service enables scientists to accelerate assay development while minimizing workflow complexity for drug discovery, immunology, and translational research applications.
Unlike electrochemiluminescence, direct chemiluminescence or enzyme-catalyzed chemiluminescence, homogeneous luminescence technology uses two types of markers: a luminescent material and a photosensitizer. The photosensitizer is distributed on the surface of donor polystyrene microspheres, while the chemiluminescent dye is distributed on the surface of acceptor polystyrene microspheres. These two types of microsphere interact via antigen-antibody binding, enabling the transfer of high-energy reactive oxygen species and triggering the light-induced chemiluminescence process. This makes "non-separation" homogeneous immunoassays possible, characterized by high precision and rapid detection.
Based on this assay platform, CD Bioparticles has developed dozens of clinically relevant tests, including those for infectious disease biomarkers, serum tumour markers, thyroid function-related hormones, reproductive hormones and cardiac emergency markers. CD Bioparticles provides comprehensive solutions ranging from homogeneous assay raw materials to technical development and large-scale production. Leveraging extensive experience in innovative R&D and mass production, CD Bioparticles assists clients in developing homogeneous, chemiluminescence-based products, thereby reducing development costs and shortening R&D cycles.
CD Bioparticles' services cover every stage, from custom conjugation to optimizing complete assay systems. This includes evaluating and screening antibodies and antigens, selecting donors and acceptors for custom antigen/antibody conjugation, optimizing conjugation conditions, optimizing reaction systems (including sample volume, donor and acceptor concentrations, and buffer systems), and validating assays. These homogeneous chemiluminescent assays can be used for biomarker detection for in vitro diagnostics (IVD), detecting protein-protein interactions, and identifying post-translational modifications.
CD Bioparticles' homogeneous chemiluminescent immunoassay development services are tailored to the unique needs of each research project. Its team of experts provides end-to-end support, including assay design, optimization, and post-market assistance. The company offers scalable, cost-effective solutions, with production processes capable of meeting a wide range of throughput requirements-from small-scale R&D needs to large-scale commercial production.
Additionally, CD Bioparticles provides high-quality donors and receptors with diverse surface characteristics and consistent quality to accommodate various conjugation methods. The company possesses extensive experience in assay design, raw material selection, conjugation and buffer system optimization, and assay validation.
CD Bioparticles offers custom services to help help researchers and diagnostic manufacturers develop homogeneous luminescence assays. To learn more about CD Bioparticles' assay development services or to request a project consultation, please visit CD Bioparticles official website at: https://www.cd-bioparticles.com/services/homogeneous-luminescence-assay-development.html.
About CD Bioparticles
CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.
Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-launches-comprehensive-homogeneous-luminescence-assay-development-services]
City: Shirley
State: New York
Country: United States
Website: https://www.cd-bioparticles.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Launches Comprehensive Homogeneous Luminescence Assay Development Services here
News-ID: 4618079 • Views: …
More Releases from ABNewswire
Unique As You Captures Nationwide Attention with Bold Statement Tees and a Heart …
Unique As You has experienced rapid growth in the statement apparel space, drawing customers who want their clothing to reflect personality and conviction. The company has also committed to supporting Ronald McDonald House Charities, inspired by a deeply personal family experience.
Buffalo, New York, USA - September 25, 2026 - Unique As You, a rising apparel brand specializing in bold statement tees for men and women, today announced a milestone period…
CPG Brands Overlook R&D Tax Credits in Product Development, K-38 Consulting Expl …
K-38 Consulting explains how CPG brands can qualify for R&D tax credits through product development, formulation, packaging, testing, and process improvements. The firm highlights common eligibility misconceptions and recommends reviewing documentation, development expenses, and prior tax years to identify potential savings.
RALEIGH, N.C. - September 25, 2026 - Consumer product companies spend heavily on developing new formulations, testing packaging, and improving shelf life - activities that frequently qualify for the federal…
Curate Launches Integrated Text Messaging for Catering and Event Teams
New two-way SMS capability keeps client conversations connected to the contact records and operational workflows teams already manage in Curate
ST. LOUIS, September 25, 2026 - Curate, an event operations platform for caterers and other special-event businesses, today announced the launch of Curate Texting, a two-way SMS capability that allows teams to send and receive client text messages directly from a Contact profile in Curate.
Curate Texting gives event professionals a shared,…
Best EHR for Solo Therapists With One-Time Payment launched by Easy Mind Care LL …
It is a new HIPAA-compliant management software built exclusively for small mental health practices. It eliminates monthly software fees entirely, and also includes unlimited clients and 100 GB of secure storage, so solo therapists can visit EasyMindCare.com to learn more.
Gastonia, North Carolina - September 25, 2026 - Easy Mind Care LLC today launched its electronic health record (EHR) platform for solo mental health therapists, introducing a one-time $149 "Founder's Club"…
More Releases for Bioparticles
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported.
Flow cytometry is a convenient detection…
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability.
The polystyrene family, a group of polymers derived from…
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications.
Low dispersion index polymers are polymeric compounds with low molecular…
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents.
CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such…
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.
With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the…
CD Bioparticles Releases Chitosans for Research Use
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies. These new chitosans and derivatives are with various water solubility, and scientists now are accessible to products like CInd™ analogous hyaluronic acid chitosan, CInd™ carboxymethyl chitosan, CInd™ chitosan azelate and glycol chitin.
One new product in this new release is the CInd™…
